International Journal of Cardiology

Papers
(The H4-Index of International Journal of Cardiology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Letter to the Editor: “Changes in walking speed 6 months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure”96
The association between microvascular complication in T2DM with HFpEF patients attending Hospital Al-Sultan Ahmad Shah81
Editorial Board62
Daily and automatic remote monitoring of implantable cardiac monitors: A descriptive analysis of transmitted episodes59
Mitral annular disjunction: A myocardial abnormality too?59
Risk of cardioembolic ischemic events and relation to atrial fibrillation/flutter in patients with arrhythmogenic cardiomyopathy during a long-term follow-up59
Stroke in ATTR cardiac amyloidosis: Does only rhythm matter?58
Seeking precision in percutaneous coronary revascularization: The best stent for each setting55
Where's the beef in anomalous coronary artery origin from an opposite aortic sinus?53
The psychosomatic impacts of social isolation on cardiac disease symptom frequency and severity51
The role of FDG-PET imaging in arrhythmogenic cardiomyopathy49
An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study48
The C2HEST and mC2HEST scores to predict the risk of new onset atrial fibrillation after presentation with acute coronary syndrome46
Impact of residual transvalvular gradient on clinical outcomes following valve-in-valve transcatheter aortic valve replacement46
Commentary to: “Prognosis of spontaneous myocardial infarction and various definitions of periprocedural myocardial infarction in patients who underwent percutaneous coronary intervention”46
Predicting antepartum arrhythmias in congenital heart disease: A step forward?46
FGF23 predicts outcomes in heart failure but questions remain unanswered46
Non-compaction cardiomyopathy and cardiovascular outcomes: A further plus point in favour of left ventricular twist45
Is there a relationship between NOAC and the neutrophil-to-lymphocyte ratio?45
Sex disparity in prognosis and costs of type 2 myocardial infarction44
Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants43
Editorial Board43
Deep vein thrombosis of upper extremities in the era of direct Oral anticoagulants41
Unstable angina: A clinical entity on the verge of extinction?41
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations40
The role of cardiac injury biomarkers as risk predictors for peripheral artery disease: Where do we go from here?39
Distal radial artery access for percutaneous coronary intervention: Convincing the sceptical cardiologist39
The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period39
Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis39
Acute neurological dysfunction: The missing link in the pathophysiology of takotsubo syndrome39
Indications, implications and safety of cardiovascular magnetic resonance (CMR) imaging in Malaysian population from the Multicentre Malaysian CMR Registry38
A peek into Malaysian Cardio oncology data – The New Kid on The Block- Single Centre experience of 10-year analysis of Neoplastic Pericardial Effusion requiring Pericardiocentensis37
COVID-19 pandemic: National outbreak and acute coronary syndrome. Collateral damages?35
Systematic review and meta-analysis of the association between all-cause mortality and statin therapy in patients with preserved ejection fraction heart failure (HFpEF)35
Any influence on outcome of hospitalized heart failure patients when ejection fraction of 60% is used as a cutoff?34
A novel genetically engineered mouse model for investigating heart failure mechanisms and therapeutic interventions34
Acute heart failure admission and outcome: A single centre contemporary appraisal34
Review on appropriate direct acting oral anticoagulant (DOAC) dose in atrial fibrillation (AF) patients in Hospital Pulau Pinang (HPP)34
0.055581092834473